Answers are grounded in this paper and cite their sources.
This viewpoint discusses glucocorticoids' role in preventing migraine recurrence in the emergency department, suggesting caution.
This Viewpoint discusses glucocorticoid recommendations for treating migraine in the emergency department (ED), describing the potential for harm that means it should not be a reflexive first-line choice for either children or adults.
No takes yet. Share an insight, caveat, or question.
Gelfand et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: